ArriVent BioPharma, Inc.
Pharmaceutical Preparations · Newtown Square, PA, United States
- PrincipalsRobin LaChapelleChief Operating OfficerStuart LutzkerPresident of R&DWinston KungChief Financial Officerand 2 more
- CompanyArriVent BioPharma, Inc.Newtown Square, PA, United States
- Phone line+1 (240) 780-6356General business
ArriVent BioPharma, Inc. is an SEC-registered Nasdaq-listed company (ticker AVBP) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 5
Finance
Winston KungChief Financial Officer
Operations
Robin LaChapelleChief Operating Officer
Legal
James Paul KastenmayerGeneral Counsel
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Robin LaChapelle — Chief Operating Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Stuart Lutzker — President of R&D
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Winston Kung — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Zhengbin Yao — President and CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Roivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityAmarin Corp PLC\UKPharmaceutical Preparations · Dublin 21 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capability